Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2
Clinical trial NCT05601401 · UNKNOWN
Trial details
- NCT number
- NCT05601401
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2023-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.